Molecular Tumor Boards: Realizing Precision Oncology Therapy.

ABSTRACT: Technological advances in high-throughput next-generation sequencing (NGS) along with advances in computational processes have brought about the dawn of the genomic medicine era. NGS has enabled molecular characterization of malignancies, and facilitated the development and approval of gene- and immune-targeted therapies, both of which impact the mutanome. Clinical implementation of this technology, approval of novel targeted agents, and establishment of molecular tumor boards has enabled precision oncology to become a reality.

SUBMITTER: Patel M 

PROVIDER: S-EPMC5760337 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature